Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The stratum corneum keratin and epidermal barrier proteins constitute the primary physical and chemical shield of the skin, essential for maintaining homeostasis and preventing environmental damage [1]. This group includes structural keratins (e.g., Keratin 1 and Keratin 10) and cornified envelope proteins like filaggrin, loricrin, and involucrin, which are cross-linked to form a resilient barrier [2]. Filaggrin is especially critical, as its degradation into natural moisturizing factors (NMFs) regulates skin hydration and pH [3]. Genetic mutations or inflammatory downregulation of these proteins are central to the pathogenesis of atopic dermatitis, psoriasis, and ichthyosis vulgaris [4]. Therapeutic strategies include the use of aryl hydrocarbon receptor (AhR) agonists like tapinarof to induce protein expression and keratolytics like urea to manage hyperkeratosis [5]. Furthermore, biologics that block IL-4 and IL-13 help restore the expression of these proteins by neutralizing the cytokines that suppress their production [6]. Sources: [1] NIH PMC5608132; [2] UniProt P04264; [3] PubMed 22134564; [4] StatPearls Atopic Dermatitis; [5] PubMed 33135112; [6] NIH PMC7395591.
Aryl hydrocarbon receptor (AhR) activation to induce protein expression; Keratolysis to soften or dissolve keratin; Vitamin D receptor (VDR) mediated differentiation; Retinoid receptor mediated modulation of keratin expression; Physical barrier supplementation.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum keratin and epidermal barrier proteins.